Page 1383 - Problem-Based Feline Medicine
P. 1383

DRUG INDEX
                                                                20 – THE CAT WITH ENLARGED LYMPH NODES  13751375






                           infusion                                                 5–7 days, then 24 until remission, then   to min. effective   4–6 wk, then   halve dosage  Continued

                      to effect  7 days       12–24                   12–24    1–2 Rx  3 days/wk  12 for  taper  dose  12 for

               8  12       12 hr  12    12  12   12  12  12  24  12  8–12  or  for









               PO  PO  IV  IV  PO  IA   PO  PO  PO  PO  PO  PO  PO  PO  IM  IM  IV  IV  PO  PO  PO  PO  PO












               20–40 mg/kg  50 mg/cat  10–20 ml/kg  0.5–1.5 g/kg  0.22 mg/kg  3–5 mg/cat  0.5 mg/kg titrate up to  0.5–0.8 mg/kg  2.5 mg; up to 10 mg/cat  0.5–2.0 mg/kg  0.5–5.0 mg/kg  2–4 mg/kg  2 mg/kg  0.5–1.0 mg/kg  2.5–5.0 mg/kg  0.1–0.2 mg/kg  2–4 mg/kg  8–20 mg/kg  50–150 mg/kg  5–10 ml/cat  25–30 mg/kg  0.5 g/m 2  15 mg/kg  0.5 g/m 2









                      Plasma volume expander  Immune-mediated diseases  Antitussive  Synovitis  failure Vasodilator: heart  Antihypertensive agent Nephrogenic diabetes insipidus  Hypoglycemia  Calcium oxalate uroliths  therapy Replacement  Anti-inflammatory  Hypoadrenocorticism  Immune mediated   hemolytic anemia   Shock  Emetic  Primary polycythemia  Chronic granulocytic leukemia












                      Hetastarch (Hydroxyethyl   starch)  Human gamma globulin  Hycodan (hydrocodone)  Hyaluronate Na  Hydralazine  Hydrochlorothiazide  Hydrocortisone  Hydrocortisone aurate  Hydrocortisone sodium   succinate  Hydrogen peroxide 3%  Hydroxyurea
   1378   1379   1380   1381   1382   1383   1384   1385   1386   1387   1388